ATAI Life Sciences N.V (NASDAQ:ATAI) price on Thursday, July 24, fall -3.61% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.74.
A look at the stock’s price movement, the close in the last trading session was $3.88. Turning to its 52-week performance, $3.91 and $1.03 were the 52-week high and 52-week low respectively. Overall, ATAI moved 77.25% over the past month.
ATAI Life Sciences N.V’s market cap currently stands at around $750.81 million, with investors looking forward to this quarter’s earnings report slated for in August.
The average forecast suggests down to a -100.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 1.38M, representing a 348.66% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATAI is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ATAI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ATAI’s current price about 31.16% and 54.51% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 75.58, while 7-day volatility ratio is 11.93% and 8.87% in the 30-day chart. Further, ATAI Life Sciences N.V (ATAI) has a beta value of 1.56. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is -33.69% off current price level while to achieve the yearly target high, price needs to move -33.69%. Nonetheless, investors will most likely welcome a -33.69% jump to $5 which is the analysts’ median price.
If we refocus on ATAI Life Sciences N.V (NASDAQ:ATAI), historical trading data shows that trading volumes averaged 4.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 199.78 million shares.
The 31.72% of ATAI Life Sciences N.V’s shares are in the hands of company insiders while institutional holders own 10.03% of the company’s shares. Current price change has pushed the stock 151.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATAI stock continues to rise going into the next quarter.
